Incidence of Leukemia in Nf1 Mice
| Genotype and Treatment . | Genotype . | No. of Mice . | No. (%) with Leukemia . |
|---|---|---|---|
| 129/Sv | |||
| None | Nf1+/+ | 31 | 2 (6%) |
| Nf1+/− | 46 | 8 (17%) | |
| Etoposide | Nf1+/+ | 26 | 0 (0%) |
| Nf1+/− | 32 | 8 (25%) | |
| CY | Nf1+/+ | 5 | 0 (0%) |
| Nf1+/− | 12 | 7 (58%) | |
| 129/Sv × C57BL/6 | |||
| None | Nf1+/+ | 14 | 0 (0%) |
| Nf1+/− | 12 | 0 (0%) | |
| CY | Nf1+/+ | 25 | 2 (8%) |
| Nf1+/− | 25 | 7 (28%) |
| Genotype and Treatment . | Genotype . | No. of Mice . | No. (%) with Leukemia . |
|---|---|---|---|
| 129/Sv | |||
| None | Nf1+/+ | 31 | 2 (6%) |
| Nf1+/− | 46 | 8 (17%) | |
| Etoposide | Nf1+/+ | 26 | 0 (0%) |
| Nf1+/− | 32 | 8 (25%) | |
| CY | Nf1+/+ | 5 | 0 (0%) |
| Nf1+/− | 12 | 7 (58%) | |
| 129/Sv × C57BL/6 | |||
| None | Nf1+/+ | 14 | 0 (0%) |
| Nf1+/− | 12 | 0 (0%) | |
| CY | Nf1+/+ | 25 | 2 (8%) |
| Nf1+/− | 25 | 7 (28%) |